{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:16:58Z","timestamp":1788225418572,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.isci.2026.116508","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:45:33Z","timestamp":1782420333000},"page":"116508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An engineered hirudin-albumin prodrug enables thrombus-targeted long-acting anticoagulation with reduced bleeding risk"],"prefix":"10.1016","volume":"29","author":[{"given":"Zhiyou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0085-9141","authenticated-orcid":false,"given":"Mingdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116508_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116508_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijlh.12688","article-title":"Global assays of fibrinolysis","volume":"39","author":"Ilich","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.isci.2026.116508_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.isci.2026.116508_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.2019002364","article-title":"Long-term treatment of venous thromboembolism","volume":"135","author":"Kearon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116508_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.116508_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hoc.2004.09.002","article-title":"The direct thrombin inhibitors: their role and use for rational anticoagulation","volume":"19","author":"Frenkel","year":"2005","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.isci.2026.116508_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood-2016-09-692996","article-title":"Emerging anticoagulant strategies","volume":"129","author":"Fredenburgh","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116508_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(94)90032-9","article-title":"The development of hirudin as an antithrombotic drug","volume":"74","author":"Markwardt","year":"1994","journal-title":"Thromb. Res."},{"key":"10.1016\/j.isci.2026.116508_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.med.45.1.165","article-title":"Hirudin: clinical potential of a thrombin inhibitor","volume":"45","author":"Johnson","year":"1994","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.isci.2026.116508_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1160\/TH07-11-0693","article-title":"The direct thrombin inhibitor hirudin","volume":"99","author":"Greinacher","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.isci.2026.116508_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.2374926","article-title":"The structure of a complex of recombinant hirudin and human alpha-thrombin","volume":"249","author":"Rydel","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116508_bib12","first-page":"2478","article-title":"Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure. Kidney","volume":"58","author":"P\u00f6schel","year":"2000","journal-title":"Int"},{"key":"10.1016\/j.isci.2026.116508_bib13","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/01.CIR.88.5.2015","article-title":"Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters","volume":"88","author":"Zoldhelyi","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.116508_bib14","first-page":"133","article-title":"Clinical pharmacology of recombinant hirudin","volume":"21","author":"Markwardt","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.isci.2026.116508_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/elsc.201700190","article-title":"Combined optimization of N-terminal site-specific PEGylation of recombinant hirudin using response surface methodology and kinetic analysis","volume":"18","author":"Wang","year":"2018","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.isci.2026.116508_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1055\/s-0038-1656077","article-title":"Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers","volume":"77","author":"Esslinger","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.isci.2026.116508_bib17","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1023\/A:1020917732218","article-title":"Albugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys","volume":"19","author":"Halpern","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.isci.2026.116508_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jconrel.2021.08.058","article-title":"Engineering a \u201cthree-in-one\u201d hirudin prodrug to reduce bleeding risk: A proof-of-concept study","volume":"338","author":"Zhu","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.isci.2026.116508_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314349121","article-title":"In situ formed depot of elastin-like polypeptide-hirudin fusion protein for long-acting antithrombotic therapy","volume":"121","author":"Tian","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116508_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mam.2008.01.001","article-title":"Thrombin","volume":"29","author":"Di Cera","year":"2008","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.isci.2026.116508_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1160\/TH07-07-0453","article-title":"Construction and functional evaluation of hirudin derivatives with low bleeding risk","volume":"99","author":"Zhang","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.isci.2026.116508_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903516","article-title":"Targeted repair of vascular injury by adipose-derived stem cells modified with p-selectin binding peptide","volume":"7","author":"Yan","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.116508_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijbiomac.2022.02.002","article-title":"A versatile insertion point on albumin to accommodate peptides and maintain their activities","volume":"205","author":"Huang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2026.116508_bib24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41467-021-21875-0","article-title":"Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins","volume":"12","author":"Mihara","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116508_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128618","article-title":"Specific inhibition on PAI-1 reduces the dose of Alteplase for ischemic stroke treatment","volume":"257","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2026.116508_bib26","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116508_bib27","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/j.1460-2075.1990.tb07410.x","article-title":"Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition","volume":"9","author":"Gr\u00fctter","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2026.116508_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","article-title":"Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study","volume":"99","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.116508_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0149-2918(02)85004-4","article-title":"Bivalirudin: a direct thrombin inhibitor","volume":"24","author":"Gladwell","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.isci.2026.116508_bib30","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1021\/bi00452a030","article-title":"Contribution of the N-terminal region of hirudin to its interaction with thrombin","volume":"28","author":"Wallace","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2026.116508_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7150\/thno.8527","article-title":"A novel tumor targeting drug carrier for optical imaging and therapy","volume":"4","author":"Li","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.116508_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.116508_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105540","article-title":"Anti-thrombotic effects mediated by dihydromyricetin involve both platelet inhibition and endothelial protection","volume":"167","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.116508_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bph.15964","article-title":"Asebogenin suppresses thrombus formation via inhibition of Syk phosphorylation","volume":"180","author":"Li","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2026.116508_bib35","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41467-024-47493-0","article-title":"Protein disulfide isomerase cleaves allosteric disulfides in histidine-rich glycoprotein to regulate thrombosis","volume":"15","author":"Lv","year":"2024","journal-title":"Nat. Commun."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:08:25Z","timestamp":1788224905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226018833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589004226018833"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116508","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An engineered hirudin-albumin prodrug enables thrombus-targeted long-acting anticoagulation with reduced bleeding risk","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116508"}}